Annual meeting September 27-28

Date: September 27-28, 2018
Location: Lysebu, Oslo, Norway

Thursday Preliminary Program
Friday Preliminary Program

Keynote speakers:

Emelia-Benjamin1-120x150

Dr. Emelia J. Benjamin, MD, MPH, has conducted research at the Framingham Study since 1988, and has served as Director of the Echocardiography and Vascular Function Laboratories and is a Member of the Executive Committee. She is Principal Investigator of the grant that recruited the second generation of the Framingham Study’s ethnic/racial minority cohort, the Omni Study. She is a Professor of Medicine and Epidemiology at Boston University. In addition to her research, she is Assistant Provost for Faculty Development for Boston University Medical Campus, and Vice Chair for Faculty Development and Diversity, BU Department of Medicine. A committed mentor, she has won local and national awards for her mentoring of early career investigators.

Patrick

Dr. Patrick T. Ellinor, MD, PhD, is Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital. He is a Professor of Medicine at Harvard Medical School and an Associate Member at the Broad Institute of MIT & Harvard. Dr. Ellinor’s research work has focused on identifying the molecular basis of atrial fibrillation. His research laboratories are located in the Cardiovascular Research Center at MGH and at the Broad Institute of Harvard and MIT. Dr. Ellinor currently helps to lead the AFGen Consortium, an international group of investigators studying the genetics of atrial fibrillation.

 

We have designated one session to oral abstract presentations. Six abstracts will be selected for presentation. Please make sure to take advantage of this great opportunity to get expert feedback on your work. Send your abstract to uxchia (at) vestreviken.no before August 15, 2018. Selected abstract presenters will be notified on September 1, 2018. Please note that there are no strict rules – your abstract may include your recently published work, work presented at other conferences, preliminary results, a study design that you would like to receive feedback on etc. The session is meant to be a friendly forum for helpful discussion and feedback.